Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

UC Irvine at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

UC Irvine brings 18 presentations to ASH 2026 in New Orleans. Its program spans leukemia, lymphoma and blood stem cell biology, from CLL drug choice to clonal blood cell growth. It also covers how Agent Orange and burn pit exposure relate to blood cancers in US veterans.

OrganizationASH 2026 Attendance
UC Irvine
Irvine, CA
Universities & research institutes
Public research university in Irvine, California; its medical center and cancer center are in nearby Orange.
Symposium
Fri Dec 11
3:00pm–6:00pm
The Rising Tide of Bispecifics in NHL: Off-the-Shelf Opportunities From Later-Line to Frontline Care
Bispecific antibodies moving from late to early treatment of non-Hodgkin lymphoma, with outpatient step-up dosing and control of immune side effects.
Symposium hosted by PeerView Institute for Medical Education
Lymphoma · New drugs
Session
Mon Dec 14
2:45pm–4:00pm
Chronic Lymphocytic Leukemia - From Clonal Evolution to Novel Therapies
Chronic lymphocytic leukemia in the targeted-drug era, covering clonal evolution, choosing and sequencing therapies, and transformation into aggressive lymphoma.
Lymphoma

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at UC Irvine

Tell us what you sell and we’ll find the people at UC Irvine most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction